McKinley Capital Management’s CONMED CNMD Stock Holding History

McKinley Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26,150	Closed	-$3.88M	–	170
2022 Q1	$3.88M	Hold	26,150	–	–	0.39%	83
2021 Q4	$3.71M	Hold	26,150	–	–	0.33%	96
2021 Q3	$3.42M	Hold	26,150	–	–	0.32%	101
2021 Q2	$3.59M	Hold	26,150	–	–	0.25%	98
2021 Q1	$3.42M	Hold	26,150	–	–	0.26%	95
2020 Q4	$2.93M	Hold	26,150	–	–	0.21%	103
2020 Q3	$2.06M	Hold	26,150	–	–	0.16%	115
2020 Q2	$1.88M	Hold	26,150	–	–	0.13%	117
2020 Q1	$1.5M	Hold	26,150	–	–	0.12%	120
2019 Q4	$2.92M	Buy	+26,150	New	+$2.79M	0.19%	101
2016 Q3	–	Sell	-730	Closed	-$35K	–	523
2016 Q2	$35K	Buy	+730	New	+$30.9K	﹤0.01%	337

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McKinley Capital Management's CNMD Position: Q2 2022 in Review

McKinley Capital Management sold out of CONMED (CNMD) in Q2 2022, closing a stake of 26,150 shares — an estimated $3.88M sold.

McKinley Capital Management first reported a position in CNMD in Q2 2016 and held it in 11 quarters. The position peaked at $3.88M in Q1 2022. 279 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

McKinley Capital Management reported no remaining CONMED position as of Q2 2022 after selling out during the quarter.
McKinley Capital Management sold 26,150 CONMED shares in Q2 2022, an estimated $3.88M.
McKinley Capital Management first reported a position in CONMED in Q2 2016 and held it in 11 quarters.
McKinley Capital Management's CONMED position peaked at $3.88M in Q1 2022.
279 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on McKinley Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.